Table 2 Baseline patient laboratory index and echocardiography before and after propensity score matching

Hemoglobin, g/L

120.5 (24.1)

112.3 (23.4)

0.005*

114.0 (23.8)

113.1 (23.0)

0.813

WBC, × 10⁹/L

6.5 (3.1)

6.9 (2.8)

0.402

6.6 (2.9)

6.9 (2.9)

0.535

NEUR, %

28.4 (30.5)

47.2 (29.6)

 < 0.001**

30.3 (31.4)

47.1 (28.7)

 < 0.001**

CRP, mg/L

5.4 (16.8)

3.9 (23.0)

0.527

8.9 (26.0)

4.5 (25.1)

0.353

Creatine, μmol/L

76.9 (24.2)

93.1 (81.6)

0.097

81.9 (40.3)

82.2 (22.2)

0.955

LDL, mmol/L

3.2 (0.9)

2.8 (0.7)

 < 0.001**

3.1 (0.9)

2.9 (0.7)

0.055

AST, U/L

21.2 (10.2)

25.2 (15.0)

0.031*

22.1 (13.4)

24.7 (14.0)

0.205

ALT, U/L

18.2 (12.9)

16.9 (11.3)

0.394

17.7 (12.4)

16.9 (10.9)

0.685

TBIL, g/L

12.1 (5.1)

12.2 (5.5)

0.955

12.0 (5.2)

11.9 (5.5)

0.91

DBIL, g/L

2.5 (1.5)

3.2 (2.8)

0.033*

2.4 (1.1)

3.0 (2.4)

0.069

CKMB, median (IQR), U/L

11.5 (9.4–14.8)

12.7 (10.3–12.7)

0.091

11.2 (9.0–14.3)

12.7 (10.5–17.0)

0.683

Myoglobin, ng/ml

34.5 (25.7–46.0)

47.2 (31.2–70.3)

 < 0.001**

39.7 (28.5–53.7)

44.1 (30.9–61.1)

0.086

CEA, median (IQR), ng/ml

3.5 (2.1–7.7)

6.5 (2.7–21.2)

 < 0.001**

4.1 (2.2–11.6)

7.3 (2.7–21.4)

0.029

CA199, median (IQR), U/L

8.5 (4.0–20.7)

11.9 (4.9–24.0)

0.216

9.5 (4.1–23.2)

11.8 (5.0–21.0)

0.353

LVEF, %

67.0 (6.0)

62.7 (9.2)

 < 0.001**

66.7 (6.9)

62.8 (8.6)

0.002*

LVEDd, mm

44.1 (5.5)

46.7 (6.7)

0.003*

44.2 (5.6)

47.0 (5.9)

0.002*

LA, mm

30.3 (4.6)

33.7 (6.1)

 < 0.001**

30.4 (4.7)

33.9 (5.5)

 < 0.001**

IVS, mm

9.4 (1.5)

10.3 (1.8)

 < 0.001**

9.7 (1.7)

10.3 (1.8)

0.018*

LVPW, mm

9.1 (1.3)

10.0 (1.5)

 < 0.001**

9.3 (1.4)

9.9 (1.5)

0.008*